Search

everythinglearnresearchcommunity

for

Search:↓

Increased regulatory T cell activity may lead to better outcomes in acute diffuse and total alopecia.

A man with skin and hair symptoms improved partially with specific treatment.

New therapies are being developed that target integrin pathways to treat various diseases.

The immune processes causing VKH and vitiligo are similar in dogs and humans.

Heat treatment increases hair loss in certain mice.

Pimecrolimus reduces the effectiveness of stem cell therapy for atopic dermatitis.

Alopecia areata and atopic dermatitis share immune system issues, and treatments like JAK inhibitors can help both.

Cyclosporine effectively treated a woman's stubborn skin condition.

Gasdermin A3 overexpression in skin causes inflammation and hair loss.

A man with a type of skin lymphoma had unusual yellowish skin growths despite normal blood lipid levels, and treatment reduced some symptoms but not the growths.

Gut microbiota influences the development of alopecia areata.

Hair follicles are normally protected from the immune system, but when this protection fails, it can cause hair loss in alopecia areata.

Malt1 protease is essential for regulatory T cell function and could be targeted to boost antitumor immunity.

Alopecia areata is caused by immune attacks on hair follicles, affecting hair growth and quality of life.

Alopecia areata involves persistent gene abnormalities and immune activity, even in regrown hair, suggesting a risk of relapse.

Eating a high-fat fish oil diet caused mice to lose hair due to a specific immune cell activity in the skin linked to a protein called E-FABP.

The document explains how the immune system reacts to organ transplants and the treatments used to prevent rejection.

Radiation therapy damages skin structure and immune function, causing inflammation and potential hair loss.

Faulty Notch signalling may cause hair follicle changes and inflammation in hidradenitis suppurativa.

The research confirms that Hidradenitis Suppurativa is characterized by increased inflammation, disrupted skin cell organization, and abnormal metabolic processes.

Four specific genes are linked to keloid formation and could be potential treatment targets.

Psoriasis involves immune and genetic factors, and understanding these can improve treatments.

Scientists are still unsure what triggers the immune system to attack hair follicles in Alopecia areata.

Entospletinib effectively prevents eye and skin GVHD in mice.

Folate receptor β helps suppress the immune system in macrophages and affects cancer growth and hair health.

Scalp involvement in primary cutaneous lymphomas is common and can be aggressive, requiring careful attention.

Systemic mastocytosis may cause a type of hair loss called cicatricial alopecia.

GPCRs are vital for wound healing by affecting cell growth and immune response.

Lymphocytes, especially CD8+ T cells, play a key role in causing alopecia areata, and targeting them may lead to new treatments.

M-CSF-stimulated myeloid cells can cause alopecia areata in mice.